feed,title,long_url,short_url
Benzinga,"FDA's Approval For Sarepta's Duchenne Gene Therapy, A Boost for Taysha Gene's Rare Neuropathy Treatment: Analyst Weighs",https://benzinga.com/analyst-ratings/analyst-color/23/05/32401775/fdas-approval-for-sareptas-duchenne-gene-therapy-a-boost-for-taysha-genes-rare-neur,https://da.gd/2aBfi4
